CACCIOLA, Rossella Rosaria
 Distribuzione geografica
Continente #
NA - Nord America 11.232
AS - Asia 4.612
EU - Europa 3.980
SA - Sud America 946
AF - Africa 238
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 6
Totale 21.024
Nazione #
US - Stati Uniti d'America 10.755
SG - Singapore 2.525
CN - Cina 1.467
IE - Irlanda 1.181
UA - Ucraina 1.100
BR - Brasile 835
IT - Italia 654
CA - Canada 415
RU - Federazione Russa 324
VN - Vietnam 168
DE - Germania 158
CI - Costa d'Avorio 118
GB - Regno Unito 114
SE - Svezia 105
IN - India 96
KR - Corea 94
FR - Francia 53
AR - Argentina 44
NL - Olanda 44
CH - Svizzera 40
PL - Polonia 38
FI - Finlandia 37
UZ - Uzbekistan 36
MX - Messico 35
BD - Bangladesh 34
JP - Giappone 26
TR - Turchia 25
EC - Ecuador 23
ZA - Sudafrica 22
AT - Austria 20
SN - Senegal 20
IQ - Iraq 17
BE - Belgio 16
MA - Marocco 16
EG - Egitto 15
ES - Italia 15
GR - Grecia 15
ID - Indonesia 15
LB - Libano 15
RO - Romania 15
CO - Colombia 13
VE - Venezuela 13
BG - Bulgaria 12
BJ - Benin 12
NG - Nigeria 12
PK - Pakistan 12
CZ - Repubblica Ceca 11
IR - Iran 11
SA - Arabia Saudita 11
AU - Australia 8
JO - Giordania 8
KE - Kenya 8
TT - Trinidad e Tobago 7
EU - Europa 6
HK - Hong Kong 6
IL - Israele 6
LT - Lituania 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
DO - Repubblica Dominicana 5
KZ - Kazakistan 5
LY - Libia 5
MY - Malesia 5
DZ - Algeria 4
PY - Paraguay 4
UY - Uruguay 4
AL - Albania 3
AZ - Azerbaigian 3
BY - Bielorussia 3
CR - Costa Rica 3
DK - Danimarca 3
KW - Kuwait 3
PH - Filippine 3
PT - Portogallo 3
TN - Tunisia 3
AM - Armenia 2
BB - Barbados 2
BN - Brunei Darussalam 2
CL - Cile 2
ET - Etiopia 2
HU - Ungheria 2
JM - Giamaica 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
BH - Bahrain 1
BO - Bolivia 1
GA - Gabon 1
GD - Grenada 1
GL - Groenlandia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HT - Haiti 1
IM - Isola di Man 1
KG - Kirghizistan 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 21.013
Città #
Dallas 2.283
Dublin 1.177
Santa Clara 1.121
Singapore 1.096
Jacksonville 1.063
Chandler 1.005
Ashburn 729
Boardman 485
Nanjing 366
Andover 322
Cambridge 319
Lawrence 318
Toronto 310
Chicago 218
Hefei 209
San Mateo 200
Des Moines 184
Los Angeles 158
Catania 147
Beijing 137
Wilmington 120
Abidjan 118
Nanchang 109
Seoul 94
Hebei 93
Saint Petersburg 82
Shenyang 82
Civitanova Marche 76
São Paulo 72
Grafing 69
Jiaxing 68
Ottawa 65
Changsha 56
Ho Chi Minh City 56
Buffalo 54
Tianjin 53
New York 49
Council Bluffs 41
Moscow 36
Houston 29
Rio de Janeiro 29
Seattle 28
Warsaw 28
Dong Ket 26
Milan 26
Brooklyn 25
Tokyo 25
Washington 25
Hanoi 24
Redondo Beach 24
San Francisco 24
Norwalk 23
Palermo 23
Phoenix 23
Pune 23
Atlanta 22
Kunming 22
Bremen 21
Den Haag 21
Dakar 20
Munich 20
Augusta 19
Liberty Lake 19
Montreal 19
Belo Horizonte 17
Boston 17
Brussels 16
Hangzhou 15
Helsinki 15
The Dalles 15
Columbus 14
Curitiba 14
Johannesburg 14
Lappeenranta 14
London 14
Porto Alegre 14
Stockholm 14
Tashkent 14
Brasília 13
Kochi 13
Abuja 12
Amsterdam 12
Ann Arbor 12
Cotonou 12
Jinan 12
Leawood 12
Poplar 12
Quito 12
Salvador 12
Ningbo 11
Mexico City 10
Mumbai 10
Elk Grove Village 9
Manchester 9
Messina 9
Princeton 9
Amman 8
Charlotte 8
Dearborn 8
Denver 8
Totale 14.268
Nome #
Elevated fibronectin plasma levels in diabetes mellitus are expression of increased synthesis and release by vascular endothe- lium. 445
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research (Internal and Emergency Medicine, (2022), 17, 3, (887-909), 10.1007/s11739-022-02967-1) 160
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 155
Contributo delle piastrine reticolate alla generazione del fattore tessutale e del fattore di crescita trasformante-beta nella mielofibrosi primaria. Reticulated platelets contribution to tissue factor and transforming growth factor-beta generation in primary myelofibrosis. 146
Clinical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electric cigarettes 134
Thrombotic risk stratification in patients with prefibrotic myelofibrosis 130
Activation of coaugulation and fibrinolysis in laparoscopic surgery 124
Acute myeloid leukemia occurring in a patient with polycythemia vera in treatment with hydroxyurea 118
A good response rate to recombinant erythropoietin alone may be expected in selected myelodysplastic patients. A preliminary clinical study 117
An unusual association between pancreatic cancer and Purtscher-like retinopathy: Presentation of a unique case 112
A cause for conversion of laparoscopic splenectomy: splenic candidiasis 109
Laparoscopic surgery: A randomised controlled trial comparing intraoperative hemodynamic parameters and arterial-blood gas changes at two different pneumoperitoneal pressure values 108
Surgical drain after open or laparoscopic splenectomy: is it needed or contraindicated? 108
D-dimer in the diagnostic work up of suspected pulmonary embolism: additional clinical value of PTP 105
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 105
Laparoscopic cholecystectomy in adult patients with sicklecell disease. 103
Activation coagulation and fibrinolysis in laparoscopic surgery 103
Abnormal plasma levels of factor VIII/von Willebrand factor complex in myocardial infarction - Expression of acute phase reaction or index of va- scular endothelium damage? 102
Acute COPD exacerbations cause alteration of the endothelium-coagulative system 102
Activation of contact phase of blood coagulation can be induced by the sclerosing agent polidocanol: Possible additional mechanism of adverse reaction during sclerotherapy 102
Activation of coagulation anf fibrinolysis in laparoscopic surgery 101
European Collaboration on Low-dose Aspirin in Polycythemia Vera (ECLAP) study: studio clinico controllato con aspirina a basse dosi per la prevenzione degli eventi trombotici nella policitemia vera. 100
Acute myeloid leukemia in elderly patients. 97
Activated factor XII and thrombin activable fibrynolysis inhibitor levels in essential thrombocythemia and polycythemia vera 97
All-trans retinoic (ATRA) induced apoptosis in pe- ripheral freshly isolated chronic myeloid leukemia cells. 96
Angiogenesis in essential thrombocythemia: fibroblast growth factor-2 and vascular endothelial growth factor cross-talk 95
Preoperative Predictive Factors of Conversions in Laparoscopic Splenectomies 95
Circulating endothelial-coagulative activation markers after smoking cessation: a 12-month observational study 95
Abnormalities of haemostatic balance in essential thrombocythemia and polycythemia vera 94
Endothelial activation and injury by cigarette smoke exposure 93
A case of acute deterioration in asthma symptoms induced by isoniazid prophylaxis 93
Il timing ottimale dell'introito di aspirina nella trombocitemia essenziale 93
Adverse outcome in non severe COVID-19: potential diagnostic coagulation tests 93
Differences in diabetes treatment of the elderly depending on observation sites. 91
Laparoscopic Splenectomy Reduces the Need for Platelet Transfusion in Patients With Idiopathic Thrombocytopenic Purpura 91
How to prevent intraoperative risks and complications in laparoscopic splenectomy 90
A Large-Scale Trial Testing the Intensità of CYTOreductive Therapy to prevent Cardiovascular Events in Patients with Polycythemia Vera (CYTO-PV trial). 90
Abnormality of the hemostatic status during stady-state phase in sickle cell/beta thalassemia. 89
Laparoscopic splenectomy in patients under the age of eighteen. Experience in 18 cases. 88
Hemocoagulative post-operative changes after laparoscopic surgery compared to open surgery: the role of lupus anticoagulant 88
Hemocoagulative Modifications after Laparoscopic Surgery at Different Pneumoperitoneum Pressure Settings. 86
Laparoscopic cholecystectomuy in adult patients with sickle cell disease 85
Abnormal production of interleukin (IL)-6 in essential thrombocythemia. 84
I disordini dell'emostasi nelle emopatie maligne. 83
Late results after splenectomy in adult idiopathic thrombocytopenic purpura. 83
Lithium and acute myeloid leukemia. 83
betaFibrinigen G-455-A gene polymorphism: is it a factor for aspirin platelet insensitivity in patients with essential thrombocythemia? 83
Splanchnic vein thrombosis in JAK2V617F-positive patients with primary myelofibrosis and lower-risk IPSS. 82
Endothelial-coagulative activation during chronic obstructive pulmonary disease exacerbation 82
The Antiphospholipid Syndrome 82
Modification of coaugulation and fibrinolysic parameters in laparoscopic cholecystectomy 82
Changes in sputum counts and airway responsiveness after budesonide: Monitoring anti-inflammatory response on the basis of surrogate markers of airway inflammation 82
"In vitro" hyperresponsivity of diabetic platelets to "saturated" platelet-activating factor (PAF). 82
Evidence for an aincreased fatty acid utilization in platelets in diabetes mellitus: its correlation withn platelet hyperfunction 81
Making, disseminating and using clinical guidelines 80
The antiphospholipid syndrome in pregnancy: a review article 80
. Trombospondin plasma levels in beta tha- lassemia:sickle cell disease 80
Alteration of endothelium-coagulative system during COPD exacerbations 80
Essential thrombocythemia and fibroblast growth factor-2: role of anagrelide 80
Chronic idiopatic trombocytopenic purpura: is there any factor to predict the response to splenectomy? 79
Effects of anagrelide on platelet factor 4 and vascular endothelial growth factor levels in patients with essentiial thrombocythemia: a preliminary report 78
La splenectomia per via laparoscopica 78
Splenic candidiasis : are perispelnic adhesions contraindications for laparoscopic splenectomy? 78
Adverse respiratory effects and allergic susceptibility in relation to particulate air pollution: flirting with disaster 78
Study on the Anagrelide on Platelet Factor 4 and Vascular Endothelial Growth Factor Levels in Patients with Essential Thrombocythemia 78
B1-Integrin expression in adult acute lymphoblastic leukemia: Possible relationship with the stem cell antigen CD34 77
Elevated plasma thrombopoietin levels and thrombosis in essential thrombocythemia: a preliminary report 77
Sopravvivenza libera da trombosi in 734 pazienti con trombocitemia essenziale (WHO 2016) stratificati secondo lo score "Revised International Prognostic Score for Thrombosis in Essential Thrombocythemia (R-IPSET-Th)". Studio del Regostro ItalianoTrombocitemie (RIT) 77
Polidocanol may directly activate the contact phase of blood coagulation during sclerotherapy 76
. Comportamento dei livelli plasmatici della trombo- spondina e della trombomodulina nella talasso-drepanocitosi 76
Laparoscopic splenectomy reduces the need of platelet transfusion in patients operated on for idiopathic thrombocytopenic purpura 76
VLA-4 and VLA-5 integrin expression in adult acute lymphoblastic leukemia. 75
Label-Free Enrichment of Circulating Tumor Plasma Cells: Future Potential Applications of Dielectrophoresis in Multiple Myeloma 74
Factor-VIII-rela- ted antigen and vasculitis. 74
Circulating endothelial-coagulative activation markers after smoking cessation 74
Platelet factor 4, vascular endothelial growth factor and prothrombin fragment 1+2 levels in essential thrombocythemia treated with anagrelide 74
Persistent generalized lymphadenopathy (transfusion-related) in an HIV - seropositive heterosexual man with sckle-cell beta-tha- lassemia. 73
PEG Intron treatment in 90 patients with assential thrombocithemia (ET) final report of a phase II study 73
Cessazione del fumo di sigaretta e riduzione dei livelli plasmatici di fattore di von Willebrand (vWF) 73
Cutaneous vasculitis in non Hodgkin's Lymphoma. 72
Thymostimulin in aplastic anaemia. 72
Alpha in- terferon as first line therapy for angioimmunoblastic lymphoadeno- pathy. Prognostic role of activated T-lymphocities. 72
Portal vein thrombosis after laparoscopic splenectomy: report on personal experience 72
Evidenza per una incrementata sintesi di fibronectina nell'endotelio vascolare di soggetti diabetici. 71
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neolpasms 71
Role of FcR+ T-cells on the mechanism of the depressed polyclonal immunoglobulin synthesis in human mye- loma. 71
Interleukin-8 levels in patients with essential thrombocythemia. 71
Anaphylactic reaction to oral prednisone : a case report and reviw of the literature. 71
MECCANISMO DI ATTIVAZIONE PIASTRINICA NELLA TROMBOCITEMIA ESSENZIALE: RUOLO DEGLI ANTICORPI ANTI CELLULA ENDOTELIALE (AACE) 70
Lom- Proteina C e potenziale fibrinolitico nel diabete mellitio di tipo II. 70
Serum overexpresion of interleukin-15 in patients with essential thrombocythemia: which significance? 70
Endothelial-coagulative biomarkers in smoking cessation 70
Surgical management of hereditary spherocytosis Current strategies 70
Effect of acute exacerbations on circulating endothelial, clotting and fibrinolytic markers in COPD patients 69
Recurrent venous thrombosis in patients with polycythemia vera and essential thrombocythemia 69
Epidèmiologie de la thalassèmie dans la Sicile Orientale. 69
Diabetes in the elderly: remarks from a epidemiological study carried out in a town of South-Eastern Sicily 68
OTTILIA and FORST : two international registries of foeto-maternal prognosis in women with recurrent reproductive failures after spontaneous or assisted conception 68
Circulating endothelial-coagulative bio-markers and smoking cessation 68
Retroperitoneal paraduodenal unicentric Castleman disease: case report and review of the literature 67
Totale 9.106
Categoria #
all - tutte 78.729
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.729


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.229 0 0 0 0 540 31 173 11 246 7 168 53
2021/20222.337 301 344 20 28 367 3 345 81 243 5 58 542
2022/20233.338 330 91 32 239 373 612 4 535 916 26 110 70
2023/20241.618 77 116 78 88 59 165 164 347 10 40 218 256
2024/20254.862 38 675 333 179 1.090 403 99 206 460 599 301 479
2025/20265.270 651 489 2.361 658 1.111 0 0 0 0 0 0 0
Totale 21.457